PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.

View in: PubMed

subject areas

Aged
Antigens, CD34
Bone Marrow Transplantation
Coronary Vessels
Double-Blind Method
Female
Humans
Infusions, Intra-Arterial
Male
Middle Aged
ST Elevation Myocardial Infarction
Transplantation, Autologous
Treatment Outcome
Ventricular Dysfunction, Left

authors with profiles

Gary Schaer